The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
I don't agree with your theory that Woodford is relying on one big winner. From memory, I seem to recall him saying of his biotech stocks he has had many many successes and only one disaster.
Being shorted by a hedge fund who have made negative comments about the company. I think it likely that Neil Woodford will offer his opinion in the coming days.
Your opinion may well be valid, but it's also possible that the directors haven't got addition funds to buy more shares, or that they're content with the exposure they now have in this company.
Has a substantial holding in this company, much of it bought at a price far higher than the current level. That's good enough for me, I'm in this morning.
Too many people treat this like a lottery ticket purchase, they want instant success. I always expected to have to wait some years for a potentially good result.
Why do you think the recent share price performance is any indication of the results not being good? Private investors may be selling recently but, I think it most unlikely they have information that is not known to everyone
Of course Neil Woodford is no guarantee of success. But, why worry if there has been no bad news? The progress that will hopefully be made by Oxp will take some years I expect.